Skip to search formSkip to main contentSkip to account menu

efinaconazole

Known as: (2R,3R)-2-(2,4-Difluorophenyl)-3-(4-methylene-1-piperidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol, (2R,3R)-2-(2,4-difluorofenil)-3-(4-metilenopiperidin-1-il)-1-(1h-1,2,4-triazin-1-il)butan-2-ol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Onychomycosis is a fungal infection of the nail, causing discoloration and thickening of the affected nail plate, and is the most… 
2019
2019
We evaluated the efficacy of efinaconazole 10% topical solution in long‐term use, for up to 72 weeks, for onychomycosis… 
2018
2018
ABSTRACT The objective of this study was to assess the in vitro activity of the novel triazole antifungal drug, efinaconazole… 
Review
2017
Review
2017
Onychomycosis accounts for 50% of all nail disease cases and is commonly caused by dermatophytes. Diabetes, human… 
Review
2015
Review
2015
Invasive fungal infections and systemic mycosis, whether from nosocomial infection or immunodeficiency, have been on an upward… 
2015
2015
OBJECTIVE To evaluate efficacy of efinaconazole topical solution, 10% in onychomycosis patients with early and long-standing… 
Highly Cited
2014
Highly Cited
2014
ABSTRACT Onychomycosis is a common fungal nail disease that is difficult to treat topically due to the deep location of the… 
Review
2013
Review
2013
ABSTRACT Onychomycosis is a common fungal nail infection in adults that is difficult to treat. The in vitro antifungal activity… 
Highly Cited
2013
Highly Cited
2013
ABSTRACT The mechanism of action of efinaconazole, a new triazole antifungal, was investigated with Trichophyton mentagrophytes…